Meros Equity
Personal Account
AZITRA INC
IPO AZTR.NYSE Past

AZITRA INC

Biopharmaceuticals

Company website
Ticker

AZTR.NYSE

Market

us

Open date

6/15/2023

IPO date

6/12/2023

About

Azitra INC is a biopharmaceutical company that specializes in developing innovative treatment methods for precision dermatology using engineered proteins and living biologic products that can be applied topically to treat skin conditions. The Azitra microbial library consists of over 60 different types of bacteria that, in our opinion, can be engineered to create living organisms or engineered proteins with significant therapeutic effects. The company operates in the promising field of AI in medical research.

Number of employees: 10

Headquarters: 21 Business Park Drive Branford, CT 06405

Meros Equity

2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.